期刊文献+

子宫内膜腺体异型增生与子宫内膜浆液性乳头状腺癌相关性研究 被引量:1

A Study of the Correlation between the Endometrial Glandular Dysplasia and Uterine Papillary Serous Adenocarcinoma
下载PDF
导出
摘要 目的:研究子宫内膜浆液性乳头状腺癌组织和癌旁组织内子宫内膜腺体异型增生腺体在免疫表型和形态学上的特征和相关性。方法:镜下观察子宫内膜浆液性乳头状腺癌和子宫内膜样腺癌癌旁组织中具有子宫内膜腺体异型增生特征的腺体,观察其形态特征,记录其数目,统计学分析,比较其与两种类型子宫内膜癌相关性的差异;S-P法对具有子宫内膜腺体异型增生的子宫内膜浆液性乳头状腺癌和癌旁组织进行P53和Ki67免疫组织化学染色,P53染色进行半定量分析,计算Ki67指数,比较不同组织区间的差异。结果:子宫内膜腺体异型增生与子宫内膜浆液性乳头状腺癌相关,子宫内膜腺体异型增生P53免疫组织化学染色强度和Ki67指数介于子宫内膜浆液性乳头状腺癌和正常子宫内膜腺上皮之间。结论:子宫内膜腺体异型增生与子宫内膜浆液性乳头状腺癌高度相关,可能是其前驱病变。 Objective: To investigate the clinic pathological and immunophenotypic features of the endometrial glandular dysplasia (EmGD) and the correlation between EmGD and uterine papillary serous adenocarcinoma (UPSC). Methods: Clinicopathological study was made on 18 cases of UPSC and 24 cases of uterine endometrial adenocarcinoma (UEC). Special attention was paid to the morphologic features and numbers of EmGD in the para - cancer tissue of UPSC and UEC. The difference of the correlation between EmGD and UPSC or UEC was analyzed. Immunohistochemical staining was performed by SP method using antibodies P53 and Ki67. Semi - quantity analysis was made on the immunohistochemical staining. Results: Compared with UEC, EmGD was highly correlated with UPSC. The values of P53 immunohistochemical staining intensity and Ki67 index of EmGD were between those of UPSC and normal resting endometrial glands. Conclusion: High correlation existed between EmGD and UPSC. EmGD probably was the precursor lesion of UPSC.
出处 《华西医学》 CAS 2007年第3期511-512,共2页 West China Medical Journal
关键词 子宫内膜浆液性乳头状腺癌 子宫内膜腺体异型增生 内膜上皮内癌 uterine papillary serous adenocarcinoma endometrial glandular dysplasia endometrial intraepithelial carcinoma
  • 相关文献

参考文献6

  • 1Hendrickson M,Ross J,Eifel P,et al.Uterine papillary serous carcinoma:a highly malignant form of endometrial adenocarcinoma[J].Am J Surg Pathol,1982,6(2):932108.
  • 2Tavassoli FA,Devilee P,et al.World Health Organization classification of tumour.pathology and genetics of tumours of the breast and female genital organs[M].International agency for research on cancer(IARC),2001:221-228.
  • 3Ambos RA,Sherman ME,Zahn CM,et al.Endometrial intraepithelial carcinoma:A distinctive lesion specifically associated with tumors displaying serous differentiation[J].Hum Pathol,1995,26:1260-1267.
  • 4Sherman M,Bur ME,Kurman RJ,et al.p53 in endometrial cancers and its putative precursors:Evidence for diverse pathways of tumorgenesis[J].Hum Pathol,1995,26:1268-1274.
  • 5Zheng W,Sharon XL,Herbert Y,et al.Endometrial glandular dysplasia:A newly defined precursor lesion of uterine papillary serous carcinoma.PartⅠ:Morphologic Features[J].Int J Surg Pathol,2004,12:207-223.
  • 6Wheeler DT,Bell KA,Kurman RJ,et al.Minimal uterine serous carcinoma:Diagnosis and clinicopathologic correlation[J].Am J Surg Pathol,2000,24:797-806.

同被引文献10

  • 1Papadia A, Gerbaldo D, Fulcheri E, et al. The risk of premalignant and malignant pathology in endometrial polyps : should every polyp be resected? [ J ]. Minerva Ginecol, 2007,59 ( 2 ) : 117- 124.
  • 2Fattaneh A,Tavassoli,Peter Devilee.程虹译.乳腺及女性生殖器肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:287.
  • 3Taylor LJ, Jackson TL, Reid JG, et al. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometlial polyps [ J]. Br J Obstet Gynaecol, 2003,110 ( 9 ) : 794-798.
  • 4Preutthipan S, Herabutya Y. Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women [ J ]. Fertil Steril, 2005,83 ( 3 ) : 705-709.
  • 5Dreisler E, Sorensen SS, Lose G. Endometrial polyps and associated factors in Danish women aged 36-74 years[ J]. Am J Obstet Gynecol,2009,200(2) : 147el-6.
  • 6McGurgan P, Taylor LJ, Duffy SR, et al. Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women [ J ]. Maturitas, 2006,54 (3) : 277-284.
  • 7Wang JH ,Zhao J,Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps : management strategies[ J]. J Minim Invasive Gynecol, 2010,17 ( 1 ) : 53 -58.
  • 8Erkanli S,Eren F,Pekin S, et al. Bcl-2 and p53 expression in endometrial carcinoma[J]. J Exp Clin Cancer Res, 2004,23 ( 1 ) : 97-103.
  • 9Maia H Jr,Maltez A,Studart E,et al. Ki-67 ,Bcl-2 and p53 expreesion in endometrial polypa and in the normal endometrium during the menstrual cycle [ J ]. B JOG,2004,111 ( 11 ) : 1242- 1247.
  • 10郭东辉.子宫内膜息肉的临床病理分析[J].中华妇产科杂志,1991,26(5):287-289. 被引量:62

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部